Company profile

Verily Life Sciences LLC

Verily Life Sciences LLC has 3 AI-enabled medical devices on the FDA list. The first decision was on January 17, 2019 and the most recent on July 19, 2022 (Study Watch with Irregular Pulse Monitor (Home), Study Watch with Irregular Pulse Monitor). Its most common review panel is Cardiovascular (3 devices).

3AI devices
2019First decision
2022Latest decision
1Specialties

Per year

2019: 12020: 12022: 1
201920202022
Verily Life Sciences LLC AI devices per year: 2019 1, 2020 1, 2022 1

By specialty

  • Cardiovascular3

Timeline

  1. Study Watch with Irregular Pulse Monitor (Home), Study Watch with Irregular Pulse Monitor · Cardiovascular · DXH
  2. Study Watch with Irregular Pulse Monitor · Cardiovascular · DXH
  3. Study Watch · Cardiovascular · DXH